Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MitoSciences

MitoSciences
2004 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of monoclonal antibodies and immunoassay for mitochondrial enzymes. The company's marketed portfolio comprises over 200 products in the areas of metabolism and apoptosis, including antibody cocktails, cell fractionation kits, sandwich ELISA kits, in-cell ELISA, flow cytometry antibodies, and enzyme activity assays.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Parent Company
Primary Office
  • 1850 Millrace Drive
  • Eugene, OR 97403
  • United States

+1 (888) 000-0000

MitoSciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MitoSciences‘s full profile, request access.

Request full access to PitchBook